tm logo

Monitor this mark

View On USPTO

ACCEL
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 28 Oct 2024

Last Applicant/ Owned by

Xyphos Biosciences, Inc.

100 Kimball Way

South San Francisco

CA

94080

Serial Number

98280621 filed on 21st Nov 2023

Registration Number

N/A

Correspondent Address

David J. Davis

David J. Davis BAKER & MCKENZIE, LLP

SUITE 5000

CHICAGO, IL 60601

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ACCEL

Biological preparations for treatment of cancer and viral-infected cells; pharmaceuticals in the nature of biologic agents for adoptive cellular therapy

Classification Information

Class [005]
Pharmaceutical Products

Biological preparations for treatment of cancer and viral-infected cells; pharmaceuticals in the nature of biologic agents for adoptive cellular therapy

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98280621

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 51164661

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
22nd Oct 2024APPROVED FOR PUB - PRINCIPAL REGISTER
21st Oct 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
21st Oct 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21st Oct 2024ASSIGNED TO LIE
21st Oct 2024TEAS/EMAIL CORRESPONDENCE ENTERED
09th Jul 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09th Jul 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09th Jul 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Jul 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27th Jun 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED